Ignite Creation Date:
2024-05-06 @ 3:12 PM
Last Modification Date:
2024-10-26 @ 1:45 PM
Study NCT ID:
NCT04556032
Status:
TERMINATED
Last Update Posted:
2020-11-04
First Post:
2020-09-09
Brief Title:
Effects of Ergothioneine on Cognition Mood and Sleep in Healthy Adult Men and Women
Sponsor:
Midwest Center for Metabolic and Cardiovascular Research
Organization:
Midwest Center for Metabolic and Cardiovascular Research
Study Overview
Official Title:
A Placebo-controlled Randomized Double-blind Trial to Assess the Effects of Ergothioneine on Cognition Mood and Sleep in Healthy Adult Men and Women
Status:
TERMINATED
Status Verified Date:
2020-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Sponsor terminated study due to unforeseen recruitment circumstances amidst the COVID19 pandemic
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to assess the effects of ergothioneine at two doses compared to placebo on cognition mood and sleep in healthy adult men and women
Detailed Description:
This will be a placebo-controlled randomized double-blind parallel-arm trial The study will consist of one screening visit 1a week 0 one baseline visit visit 1b week 0 and three treatment visits visits 2 3 and 4 weeks 4 8 and 16
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None